Evidence map›Paper›PMID 25279375›Full record

ReviewFrontiers in bioengineering and biotechnology2014

Synechocystis: Not Just a Plug-Bug for CO2, but a Green E. coli.

Filipe Branco Dos Santos, Wei Du, Klaas J Hellingwerf

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Heterologous Lactate Synthesis inApplied and environmental microbiology · 2022
    Article
  6. Article
  7. The survivor strain: isolation and characterization ofFrontiers in bioengineering and biotechnology · 2022
    Article
  8. Untargeted Lipidomics Analysis of the CyanobacteriumInternational journal of molecular sciences · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Expanding the toolbox forSynthetic biology (Oxford, England) · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Filipe Branco Dos SantosMolecular Microbial Physiology Group, Faculty of Life Sciences, Swammerdam Institute of Life Sciences, University of Amsterdam , Amsterdam , Netherlands.
Wei DuMolecular Microbial Physiology Group, Faculty of Life Sciences, Swammerdam Institute of Life Sciences, University of Amsterdam , Amsterdam , Netherlands.
Klaas J HellingwerfMolecular Microbial Physiology Group, Faculty of Life Sciences, Swammerdam Institute of Life Sciences, University of Amsterdam , Amsterdam , Netherlands ; Photanol B.V. , Amsterdam , Netherlands.
University of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following multiple reports warning for threats posed by raising levels of atmospheric CO2, it is of paramount importance that human society rapidly evolves to be sustainable. Processes relying on photosynthetic microorganisms, converting CO2 and water into compounds of interest, fueled by light, are very pertinent, particularly if not directly competing for arable land. Here, we identify specific research questions that remain to be targeted to exploit the full potential of cyanobacterial cell factories. We argue that this approach will be more likely to be successful if organisms such as Synechocystis are not perceived as mere chassis for CO2 fixation, but rather considered as the "green" E. coli.

Indexed as

genetic engineeringphotosynthesissustainabilitySynechocystissystems biology

Identifiers

PMID25279375
PMCPMC4166995
OpenAlexW2121595265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.